In hemorrhagic stroke, rhCDNF treatment did not increase the density of ARG1-positive cells, but rather modestly decreased the density of CD68-positive cells in the lateral peri-hematoma striatum (Fig. S7A–D). Here, ARG1 is linked to hemorrhagic stroke.